[{"id":"dbfdbd9d-73ab-4827-83ef-61d4836d6bd2","acronym":"","url":"https://clinicaltrials.gov/study/NCT05414136","created_at":"2022-06-10T13:57:05.861Z","updated_at":"2024-07-02T16:35:34.049Z","phase":"Phase 1","brief_title":"Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006","source_id_and_acronym":"NCT05414136","lead_sponsor":"Bio-Thera Solutions","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BAT1006"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 37","initiation":"Initiation: 02/10/2022","start_date":" 02/10/2022","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2023-10-10"}]